Mesa Laboratories Inc: (NASD: MLAB)
$53.24
-2.02 (-3.66%)
Volume 41,800
May 21 04:00 PM ET
Zacks Rank: NA 
| |
Financial Overview
P/E
| PE (forward) | NA |
| Trailing 12 Months | 19.88 |
| PEG Ratio | NA |
Price Ratios
| Price/Book | 3.70 |
| Price/Cash Flow | 16.08 |
| Price / Sales | 4.23 |
Current Ratio
| 03-31-13 | NA |
| 12-31-12 | 4.30 |
| 09-30-12 | 4.96 |
Net Margin
| 03-31-13 | NA |
| 12-31-12 | 18.32 |
| 09-30-12 | 20.30 |
Inventory Turnover
| 03-31-13 | NA |
| 12-31-12 | 3.34 |
| 09-30-12 | 3.29 |
EPS Growth
| vs. Previous Year | -11.11 |
| vs. Previous Quarter | -26.32 |
ROE
| 03-31-13 | NA |
| 12-31-12 | 20.85 |
| 09-30-12 | 22.37 |
Quick Ratio
| 03-31-13 | NA |
| 12-31-12 | 2.93 |
| 09-30-12 | 3.29 |
Pre-Tax Margin
| 03-31-13 | NA |
| 12-31-12 | 28.04 |
| 09-30-12 | 31.13 |
Debt-to-Equity
| 03-31-13 | NA |
| 12-31-12 | 0.10 |
| 09-30-12 | 0.17 |
Sales Growth
| vs. Previous Year | 22.70 |
| vs. Previous Quarter | -2.95 |
ROA
| 03-31-13 | NA |
| 12-31-12 | 16.00 |
| 09-30-12 | 17.35 |
Operating Margin
| 03-31-13 | NA |
| 12-31-12 | 22.24 |
| 09-30-12 | 23.93 |
Book Value
| 03-31-13 | NA |
| 12-31-12 | 14.92 |
| 09-30-12 | 14.46 |
Debt to Capital
| 03-31-13 | NA |
| 12-31-12 | 9.08 |
| 09-30-12 | 14.19 |
